Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
Europe has a scale-up fund with a €5 billion target. The European Commission has put in €1 billion, and that is the only commitment we could find disclosed by name. Europe has a new company for startups. It is still a proposal, and the European Parliament has not yet voted on it. Europe has a new rulebook for public buyers. The target for finishing the negotiations is end
Europe is adding growth capital faster than it is removing the barriers to scaling. The question for 2031 is whether its best companies can grow globally without having to move their strategic center out of Europe. This is Startuprad.io, your startup podcast and YouTube
channel on startups and venture capital in Europe with focus on Germany, Austria, and Switzerland. Hello and welcome everybody, my name is Joe. I am coming to you from Frankfurt am Main, Germany, and this is part number 8 of our series, The European Scale-Up Question or The European Scale-Up Gap. For 7 episodes, we diagnosed the problem Today we ask what would actually have to change between, say, 2027— we're very close to it— and 2031 for Europe to produce more globally scaled technology companies.
And we write down how we will check. It's 2 years after the Draghi report. The Joint European Disruptive Initiative tracked the follow-through. According to its Draghi Tracker, about a quarter the recommendations have been implemented. Europe does measure its startup conditions. The European Commission publishes a Startup and Scale-Up Scoreboard with 36 indicators comparing member states. What nobody tracks in public is the outcome for the same companies
over time— which ones scaled, which ones moved, and which ones failed. This is the gap. This episode tries to fill. So today I separate 3 things: policy announcement— what governments and institutions say they will do— infrastructure changes— what actually alters the conditions under which companies scale— and observable outcomes— what founders, investors, and customers then do differently. Most of the
debate is about the first This episode is more about the third. So here's my thesis in one breath: Europe is adding growth capital faster than it's removing some of the barriers to scale. This creates a risk— companies may still need to relocate to grow. Our scorecard will test whether they can scale globally while keeping their strategic center in Europe, and it will
reward the cases that prove us wrong. I call the timing mismatch the sequencing gap. A new program is an input. A company scaling differently is an outcome. This episode rates Europe on outcomes. Where we are in the argument: Part 1 defines the scale-up gap in our overall series. I mean, Part 2 called fragmentation a hidden growth tax. Part 3 of our scale-up series showed a capital architecture
breaks between the rounds. Part 4 was demand that does not turn into deployment. Part 5 was talent that does not recycle. Part 6 introduced capital gravity, and Part 7 showed that Europe's strongest hubs do not add up to one market. In Parts 6 and 7, we We put a forecast on record. The EU Inc. will not apply before January 1st,
2028, at 75% confidence. That forecast stays still on record and we'll score it on that date. Well, maybe a few days later because, you know, New Year's. Anyway, today I add a second stricter one. Defining scale infrastructure. First, a definition, because we will use this from now on. Scale infrastructure is the set of financial, commercial, institutional,
and human systems that lets a company grow from product-market fit into global leader without rebuilding its operating environment every time it grows. Startup Radio's way to measure it is the the Scale Infrastructure Scorecard. It has 5 tests, and each test asks about companies' behavior, not government announcements. Number 1, capital. Can a company raise its
next growth round without having to move its parent company? The market. Can they expand into another European country as a domestic decision. Demand— can it win repeat European customers, not just pilots? People— do its operators come back as founders and angels? Retention— as it grows,
do its parent company, its leadership, and its listing stay in Europe? And here is how we keep it honest. We do not pick like the best 50 companies in 2031. That would, uh, kind of select the answer. We fix the group now. Our cohort is every company headquartered in Europe that announced funding of €100 million or more in calendar year 2026. We freeze that list
at the end of January 2027. And publish it. Every company stays in the cohort, including the ones that fail, get acquired, or relocate. Each year we score every company on the 5 tests and we publish results, including the cases that contradict us. Before I make my case, the strongest opposing argument, it goes something like this: capital buys time. Europe's reforms are slow, so the
best thing a growth fund can do is keep good companies funded until the rules catch up. And international investors are not a threat. A strategic investor can bring customers and supply chain. An American fund can bring expertise and access to the largest market in the world. A company can take that money, list in New York, hire commercial team in California, and still be a European company in every way that matters— research, engineering, leadership, tax. I think that argument
is largely right, and I want to say so clearly. Foreign capital can help European companies become global leaders. So the risk I'm casting is narrower. The failure is not foreign money, as I said before. The failure is a company having to relocate its strategic center in order to get the money, the customers, or the listing it needs. The European Central Bank names that risk. It says
foreign investors often provide the additional funding European scale-ups need and that they may increase the likelihood of headquarters relocating. May is the important word. Whether it happens is exactly what our scorecard measures. Test number 1, capital. Can Europe finance its winners? What happened? The Scale-Up Europe Fund targets about €5 billion. The European Commission committed €1 billion.
EQT manages it. It invests in rounds of €100 million and above. In August, it co-led ICEYE's €1 billion financing round, which includes €450 million of primary Series F capital and a valuation above €10 billion. In September, Samsung Electronics and the Scale-Up Fund Europe co-led Mistral AI's €3 billion Series D.
On the 10th of July, the EIB Group announced the European Tech Champion Initiative 2.0. With a fundraising target of up to €15 billion. And on the 22nd of September, the Commission and the EIB launched an Institutional Investor Pact with 13 institutions saying they intend to invest in Germany. KfW reported that €2.64 billion had been invested under the
WIN initiative at the end of 2025 against a goal of €12 billion by 2030. KfW counts investment through funds, funds of funds, direct investments, and debt such as venture debt. There is no published year-by-year schedule, so that figure tells us progress, not whether the WIN initiative is on pace. Why it matters structurally. There are 3 different numbers in every headline about the European Growth
Capital: a target, is what a program aims for. A commitment is money promised, and deployment is money in a company. On the Scale-Up Europe fund, we searched on November 3rd the EIC fund page, EQT's announcement, the EIB, the track price. We found no published total of commitments beyond the Commission's €1 billion. That is a disclosure gap. It is not proof that the money is
missing, but a public fund should publish its closing figure, and we will report if it ever does so. The capital test is one question: can a European company raise its next growth round at €100 million plus without investors requiring it to move its parent company out of Europe? Not one big round— round after round until the answer My answer is routinely yes. Europe has growth funds, but it does not yet have
capital continuity. What would change my mind? If, say, by 2028, most cohort companies that raise again do so with a European lead or co-lead and without changing their parent company, the capital test is passing. Whether the headline Fund sizes say. If instead redomiciliation clauses— so moving headquarters clauses— start appearing in term sheets as a condition of the next
round, the risk is real. What I will measure for every company in 2026 cohort, each later round, who led it and whether the parent company stays where it is. Test number 2, market. Can Europe behave like a home market? What happened? On the 18th of March 2026, the Commission proposed EU Inc., the so-called 28th regime, as a regulation.
Online registration within 48 hours at a maximum cost of €100, with no minimum capital and a European employee stock option rule that defers taxes until shares are sold. It does not include a pan-European corporate tax regime. On the 23rd of October, the member states agreed to the Council's negotiation position. Registration in 2 days for 100 euros survives. Board-level employee participation
follows the rule of the country where the company has its registered office. The Council limits the stock option tax treatment to companies up to 750 employees and €150 million in turnover, and it sets a 21-month implementation period after the regulation enters into force. The European Parliament had not adopted its position by late October. Reports say the Legal Affairs Committee vote was postponed twice in October
over employee participation. Negotiations with the Council cannot start until Parliament has voted. Why it matters structurally: EU Inc. fixes the first day of company's life. Much of the cost of fragmentation comes later: employment law, payroll, local tax, sector licenses. Those stay national. On the stock options, the Council's limit could exclude larger scale-ups. What happens to options
granted before company crosses that line is not yet clear, and that needs to be clarified before founders can plan around it. Here's my own arithmetic on the timeline, and it is an estimate, of course, not a fact. If Parliament votes in the coming weeks, negotiations with the Council run into 2027. After the agreement comes formal adoption, publication, and entry into force. Add the Council's 21 months and the
first registration lands somewhere in 2029. That is where my forecasts later in this episode comes from. What people get wrong: they treat EU Inc. as the market test. It is the entry ticket. Market test is whether a company in Munich can hire in Lisbon, sell to Warsaw, and grant equity in Vienna without rebuilding its legal setup each single time. Before the demand test, which is whether evidence is more encouraging
than people think, a quick word from our partners. Startuprad.io helps selected partners reach founders, investors, and operators across Europe, especially Germany, Austria, and Switzerland. If you want to build credibility with these decision-makers, explore a partnership at startuprad.io/become-a-partner. And stay with me because after the demand test, I will give you a forecast you can hold me to.
Test number 3, demand. Will you buy what it builds? And here I want to start with a counterexample to my own series. Yes, I know. In part 4, we called it demand without deployment. Public money funds the supply of innovation, but the public buyer does not become the customer. Now look at ICEYE. According to EQT's announcement, ICEYE already delivers sovereign satellite systems
for 7 European governments, and it's delivered an operational capability to Poland less than 12 months after the contract was signed. ICEYE shows that European reference demand can work. A European company won European governments as customers and delivered it under a year. The question for 2031 is not whether this is possible, it is whether it becomes routine across sectors for companies that are not already leaders.
Count the repeat contracts, not the pilots. A pilot tells you a buyer is curious. A repeat contract tells you a buyer depends on you. What happened to the rules? On the 9th of September 2026, the Commission proposed the Public Procurement Act, one directly applicable regulation instead of 3 directives: a European preference in awarding contracts,
simplified procurements that the Commission says will save public buyers time, and a minimum 30% weight for quality criteria, innovation among them, subject to the comply or explain rule. The political target is to conclude negotiations by the end of 2027. So why does this matter structurally? The proposal does contain machinery meant to make procurement faster and reward quality. What is unproven is whether it will.
Comply or explain lets a buyer opt out with a reason. Simpler procedures save time on paper. The test is the time from tender to deployment in practice. What I will measure: for the cohort, announced European public or industrial contracts and how many are repeat or framework contracts. At the system level, time from tender to operational deployment where buyers publish it.
Test number 4, people and experience compound. In part 5 of the series that We argued that Europe produces talent, but scaling experience does not recycle fast enough, meaning employees who once scaled go back into companies that are scaling. The operator who took a company from 100 to 1,000 people should become the angel, the founder, or the board member of the next companies.
2 signals matter. First, employee ownership. Equity that employees build is what can turn operators into angels, which is why the scope of the EU stock option rule matters. Second, where founders and operators base themselves. Atomicos' 2025 Founder Survey found that 15% of surveyed founders had moved their headquarters abroad, and 57% of those had moved to the United States.
What people are getting wrong here— they count startups founded and visas issued. Those are inputs. The outcome is experienced people building the next company in Europe. What it will measure for the cohort: new companies founded by alumni of cohort companies and where those new companies are based. The baseline goes into the first annual scorecard in November 2027. Test number 5, retention. Do the winners stay? This is capital gravity
turned into a scorecard line, and I want to be precise about it. Some good news first. EY reports that European IPO numbers rose 35% and proceeds 28% in the first 3 quarters of 2026 compared with the previous year. On the 8th of October, the council agreed a position agreed-to position that would move supervision of largest trading venues and post-trade infrastructure to the European Securities
Regulator, ESMA. Now the position— we score retention as 4 separate indicators, not simply one. Where's the parent company incorporated? Where does the chief executive work? Where is senior commercial leadership based? And where is the company listed or expected to list? A US listing alone is not a failure. A US sales team alone is not a failure. What we look for is the
pattern— several of those moving out of Europe while the engineering stays. And remember the definition: a parent company in Zurich or London counts as European in our scorecard. The sequencing gap. Now put the 5 tests on a timeline. Capital arriving now. The Scaleup Europe Fund has been investing since August 2026. ETCI 2.0 is fundraising.
The market arrives later. EU Inc. is not law. Parliament has not voted and the Council's text gives member states 21 months after the entry into force. Procurement reforms arrive later still. Agreement is targeted for the end of 2027, and then it has to be applied. So many companies financed by Europe's new growth money will scale for some years under today's rule. Some
will do it very well, as ICEYE shows. The risk is that others will need to move their strategic center to get the next round— the customers or the listing. That is the sequencing gap. It is a risk to test, not a verdict. 3 scenarios for 2031. Scenario number 1: Sequence Europe. EU Inc. is agreed in '27. and becomes usable
in '29 with employee equity that still works for larger companies. The procurement act is agreed and buyers start running repeat contracts with young companies. The growth funds reach their targets and keep investing through a downturn. In that world, most cohort companies pass most tests. Another scenario, scenario number 2. Capital First Europe, the funds deploy, but market rules stays national in practice.
Europe gets more large rounds, and a meaningful share of cohort companies move their parent company or leadership abroad to reach the next stage. The capital test improves, the retention test does not. And on today's legislative calendar, I think this scenario deserves some serious weight. Scenario number 3, stall. A downturn arrives before the instruments are completed. Institutional investors pull back, targets slip, and legislative piles lose
priority. What separates scenario 1 from number 2 is timing. The decision about where a parent company sits often comes around the later growth rounds or before an IPO. For companies raising large rounds in '27 or '26, that is roughly '28 to 2030. The window is real and is narrow. What would prove us wrong? Every thesis
in this series should be falsifiable. So here's what would prove This one wrong. First, most cohort companies pass retention tests under today's rules. Before EU Inc. and procurement reforms apply, then the sequencing gap was not binding. Capital was enough, and I will say so on the show. Second, if the cohort shows relocations even after
reforms are in place, then the problem was never the order of the instruments. It was something deeper, like market size or valuation, and the next part of this series will have to go there. Third, if European public and industrial buyers turn more cohort companies into repeat customers, as ICEYE shows is possible, the demand test passes and part 4 of this series Needs an update. That would be actually a good problem to have.
Milestones we'll be watching, '27 to 2031. The milestones I will track, in order: next European Parliament's vote on EU Inc. Until that happens, nothing can be negotiated. January '27, we freeze and publish the 2026 cohort. In '27, Whatever the scale-up your fund publishes as a closing figure and whether ETCI 2.0 confirms the
size of its first closing. By the end of '27? Whether the Public Procurement Act and the Savings and Investment Union supervision package are agreed, as the political targets say. The Commission is also due to report on its startup and scale-up strategy By the end of '27. November '27, 12 months out, the first annual scorecard for the cohort, then every November until 2031. Forecast.
Here's my forecast on record. No company will be able to register as an EU Inc. anywhere in the European Union before January 1st, 2029. My confidence is 70%. The reason is simply the calendar. As of late October 26th, the European Parliament had not adopted its position, and negotiations with the member states cannot start until it does.
This sits next to our earlier forecast, not instead of it. The Part 6 forecast, no EU Inc. before January 1st, 2028, at 75% stays on record. And it will be scored on that date. 2 more predictions. First, the Scale-Up Europe Fund will not publicly confirm that commitments of €5 billion or more before June 30th, 2027. Confidence 65%.
Second, the Public Procurement Act will not be formally adopted before end of '27. Confidence 65%. And our part 6 forecast stays open as originally worded. By the end of '27, at least one scale-up fund Europe portfolio company will have a parent holding company outside of the EU. Note that this one is about the EU, so a Swiss or British parent
would count. Still 60%. Our synthesis. So what connects all of this? Europe's instruments are no longer missing. Their timing is uneven and their effect is unproven. Each test depends on the others. Growth capital helps most when the company can also hire, sell, and grant equity across Europe, and when European buyers become repeat customers. The game changes when the
5 tests turn green for the same companies at the same time. And if the cohort shows that companies scale globally and keep their strategic center in Europe under today's rules, we will say so. Operator and investor split. If I were fundraising in '27, I would do 3 things. I would plan my next growth rounds as a sequence and ask every lead investor in writing whether
any future round assumes a change of parent company or listing venue. I would build an employee equity plan that works today across countries and can migrate later rather than waiting for EU Inc. And I would decide deliberately where my first large reference customer comes from. For some companies, early US expansion is right commercial decision. If you go to the US first, decide in advance which functions
and which decision rights stay in Europe. If I were an investor, I would underwrite European growth rounds on the follow-on path, not the single check. I would track the full retention indicators for early growth stage companies separately, and I would treat the €100 million line as the point where your co-investors are now present and worth bringing in early. If you want to go deeper, the
Startuprad.io Founder Vault contains the working tools behind this episode: our Scale Infrastructure Scorecard, the indicators we are tracking through 2031, and practical questions for growth financing and corporate location decisions. Members also get our analysis of targets, commitments, and actual capital deployment, plus the investor diligence checklist. Join through YouTube
membership or Substack. Both links are in the show notes. Thank you for listening to part 8 of the European Scale-Up Question. The single idea to take you— to take with you A program is an input. A company scaling differently is an outcome. We have fixed the cohort rules today, so we cannot choose the answer later. We'll come back to this every November until 2031. If
If this analysis helped, share it with a founder or investor facing a major growth decision. And if you know a European company that challenges our thesis, send us the evidence. Subscribe to Startuprad.io for future updates to the scorecard. All eight parts of the series are linked in the show notes. This was Startuprad.io. My name is Joe. Take care and see you next time. Bye.
Climate tech hardware in Germany rarely fails on technology. It fails between pilot and plant, in a €5 million to €50 million gap that is too big for angels and too risky for most funds. Business angel Birte...
Helsing Clarity: How AI Agents Fuse Battlefield Data Helsing's Clarity runs hundreds of specialised AI agents over satellite imagery, drone video, signals and written reports. They share one military data model and one...
Germany chose physical AI: NVIDIA plans stakes in Agile Robots, Avelios, Mirelo and Reflex Aerospace; RobCo passes $1B; Zurich's Enact raises a $30M pre-seed. A note on timing: because of my travel schedule, this...
E 783 - Laser Fusion Spin-Off: How TU Darmstadt Built It Laser fusion is the hardest deep tech bet in Germany: huge capital, more research, a plant targeted for the mid-2030s. Focused Energy took it with a $240M Series...
Deep tech in Europe has a lab-to-market problem you can measure. Jörn "Joe" Menninger reads the European Commission's study of 168 European and 144 US hubs: close to US levels on joint research, far behind on joint...